Previous 10 | Next 10 |
home / stock / npth:cc / npth:cc news
Delivered record second quarter total revenue of $17.1 million Adjusted EBITDA (1) of $1.0 million, our 18 th consecutive quarter of positive adjusted EBITDA, which improved significantly year-over-year Net profitable quarter with positive cash flow Substantially i...
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced the voting results from its Annual General and Special Meeting of Shareholders (the “Mee...
Delivered first quarter revenue of $16.1 million, up 4.2% year over year Adjusted EBITDA (1) of $0.7 million, our 17 th consecutive quarter of positive adjusted EBITDA Continued focus on operational improvements and new services to better serve our patients Neu...
Received a positive response from the Canada Revenue Agency (the “CRA”) to our Notices of Objection regarding the Harmonized Sales Tax (“HST”) matter previously disclosed in our financial statements The CRA has provided updated Notices of Reassessment and will ...
NeuPath Health Inc. (TSXV:NPTH), (“ NeuPath ” or the “ Company ”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced it has closed its previously announced brokered private placement offering of 10% s...
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced that Joseph Walewicz, CEO, will be presenting at the 2023 Bloom Burton & Co. Healthcare Inv...
NeuPath Health Inc. (TSXV:NPTH), (“ NeuPath ” or the “ Company ”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced a proposed offering of up to 1,400 units of the Company (the “ Units ...
Delivered record fourth quarter revenues of $16.1 million Adjusted EBITDA (1) of $0.8 million, our 16 th consecutive quarter of positive adjusted EBITDA Recent clinic openings and expanded service offering to drive further momentum, continued focus on operational improveme...
Reports continued growth in revenues for Q4 and 2022 Operational savings have improved adjusted EBITDA (1) and cash flows Repaid $1.6 million in debt in 2022 Recent clinic openings to drive further momentum, continued focus on operational improvements to better serve o...
Received binding offer to purchase London medical facility, closing August 1, 2023 Two London clinics to be co-located in a newer facility to better serve our patients Net proceeds will further reduce debt, eliminating mortgage on the medical facility Annualized operating ...
News, Short Squeeze, Breakout and More Instantly...
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced the voting results from its Annual General and Special Meeting of Shareholders (the “Mee...
Delivered record first quarter total revenue of $17.5 million, up 9% year-over-year Adjusted EBITDA (1) of $0.9 million, our 21 st consecutive quarter of positive adjusted EBITDA Improved cash flows, closing cash and cash equivalents balance of $2.6 million, up more than 3...
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced that Joseph Walewicz, CEO, will be presenting at the 2024 Bloom Burton & Co. Healthcare Inv...